AYUMI Pharmaceutical Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
369
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
AYUMI Pharmaceutical General Information
Description
Manufacturer of specialty pharmaceuticals designed for managing rheumatic diseases and orthopedic pain. The company offers anti-rheumatic drugs, analgesics, biosimilar biologics, orthopedic pain medications, prescription therapeutics, and medical drugs, providing healthcare institutions with specialized medications that help patients manage chronic autoimmune conditions and physical health.
Contact Information
Website
www.ayumi-pharma.com(Operating Subsidiary)
Corporate Office
- 19th Floor, Kabuki-za Tower
- 4-12-15 Ginza, Chuo-ku
- Tokyo, 104-0061
- Japan
Corporate Office
- 19th Floor, Kabuki-za Tower
- 4-12-15 Ginza, Chuo-ku
- Tokyo, 104-0061
- Japan
AYUMI Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AYUMI Pharmaceutical Comparisons
Industry
Financing
Details
AYUMI Pharmaceutical Competitors (15)
One of AYUMI Pharmaceutical’s 15 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Connect Biopharmaceuticals | Formerly VC-backed | Taicang, China | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Brii Biosciences | Formerly VC-backed | Beijing, China |
AYUMI Pharmaceutical Patents
AYUMI Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12653797-B2 | Tablet and method for manufacturing same | Active | 03-Jul-2020 | ||
| US-20230255907-A1 | Tablet and method for manufacturing same | Active | 03-Jul-2020 | ||
| WO-2022004871-A1 | Tablet and method for manufacturing same | Inactive | 03-Jul-2020 | ||
| JP-7652778-B2 | Tablets and their manufacturing method | Active | 03-Jul-2020 | ||
| JP-7360460-B2 | Orally disintegrating tablet and its manufacturing method | Active | 07-Jun-2019 |
AYUMI Pharmaceutical Signals
AYUMI Pharmaceutical Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
AYUMI Pharmaceutical FAQs
-
When was AYUMI Pharmaceutical founded?
AYUMI Pharmaceutical was founded in 2015.
-
Where is AYUMI Pharmaceutical headquartered?
AYUMI Pharmaceutical is headquartered in Tokyo, Japan.
-
What is the size of AYUMI Pharmaceutical?
AYUMI Pharmaceutical has 369 total employees.
-
What industry is AYUMI Pharmaceutical in?
AYUMI Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is AYUMI Pharmaceutical a private or public company?
AYUMI Pharmaceutical is a Private company.
-
What is the current valuation of AYUMI Pharmaceutical?
The current valuation of AYUMI Pharmaceutical is .
-
What is AYUMI Pharmaceutical’s current revenue?
The current revenue for AYUMI Pharmaceutical is .
-
Who are AYUMI Pharmaceutical’s investors?
Blackstone, Hisamitsu Pharmaceutical, M3, Santen Pharmaceutical, and Toho Holdings are 5 of 6 investors who have invested in AYUMI Pharmaceutical.
-
Who are AYUMI Pharmaceutical’s competitors?
Genentech, BioMarin Pharmaceutical, Connect Biopharmaceuticals, Merck & Co., and Brii Biosciences are some of the 15 competitors of AYUMI Pharmaceutical.
-
When was AYUMI Pharmaceutical acquired?
AYUMI Pharmaceutical was acquired on 01-Jul-2026.
-
Who acquired AYUMI Pharmaceutical?
AYUMI Pharmaceutical was acquired by GNI Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process